4100 SW 15TH ST
⭐ 4.5
Metabolic medicine provider specializing in medical weight management, bariatric care, and GLP-1 treatment in Topeka, Kansas.
In-PersonInsurance
Weight Loss Clinics in Topeka, Kansas
Looking for a weight loss clinic that prescribes GLP-1 medications? Our directory lists 19 verified providers serving Topeka, Kansas (125,467 residents · 37.6% adult obesity).
Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.
Top 10 GLP-1 Clinics in Topeka
3310 SE 29TH ST
⭐ 4.5
Metabolic medicine provider specializing in medical weight management, bariatric care, and GLP-1 treatment in Topeka, Kansas.
In-PersonInsurance
1111 SW GAGE BLVD STE 100
⭐ 4.5
Metabolic medicine provider specializing in medical weight management, bariatric care, and GLP-1 treatment in Topeka, Kansas.
In-PersonInsurance
6730 Sw 29Th St, Topeka, KS 66614
⭐ 4.2
Dr. Bahaa Abu Bakr, MD is a endocrinology specialist in Topeka, Kansas.
OzempicMounjaroRybelsusIn-PersonInsurance
6730 Sw 29Th St., Topeka, KS 66614
⭐ 4.2
Dr. Richard Fairchild, MD is a endocrinology specialist in Topeka, Kansas.
OzempicMounjaroRybelsusIn-PersonInsurance
6730 Sw 29Th St, Topeka, KS 66614
⭐ 4.2
Dr. Bahaa Abu Bakr, MD is a endocrinology specialist in Topeka, Kansas.
OzempicMounjaroRybelsusIn-PersonInsurance
3520 Sw 6Th Ave, Topeka, KS 66606
⭐ 4.2
Dr. Noor Addasi, M.D. is a endocrinology specialist in Topeka, Kansas.
OzempicMounjaroRybelsusIn-PersonInsurance
3520 Sw 6Th Ave, Topeka, KS 66606
⭐ 4.2
Dr. Dana Awad, MD is a endocrinology specialist in Topeka, Kansas.
OzempicMounjaroRybelsusIn-PersonInsurance
3520 Sw 6Th Ave, Topeka, KS 66606
⭐ 4.2
Dr. Susan Brian, MD is a endocrinology specialist in Topeka, Kansas.
OzempicMounjaroRybelsusIn-PersonInsurance
3520 Sw 6Th Ave, Topeka, KS 66606
⭐ 4.2
Dr. Francisco Correa, MD is a endocrinology specialist in Topeka, Kansas.
OzempicMounjaroRybelsusIn-PersonInsurance
More GLP-1 Resources
Browse All GLP-1 Clinics →
Full directory of verified providers on GLP1Maps.com
Clinic Owner? →
Get an AI Receptionist that books patients 24/7 — from GLP1Receptionist.com
New to GLP-1? →
Read Shep's Method — patient guide to GLP-1 success at ShepsMethod.com
Independent network of GLP-1 resources serving Topeka and patients across the U.S.
What to Look for in a GLP-1 Clinic
Choosing the right GLP-1 provider in Topeka matters. Look for clinics that offer:
- Board-certified physicians or NPs with experience in metabolic medicine
- FDA-approved medications (Ozempic, Wegovy, Mounjaro, Zepbound) — not unverified compounded versions
- Comprehensive lab work before starting therapy
- Ongoing monitoring — weight, side effects, dose adjustments
- Transparent pricing — monthly costs, insurance acceptance
- Real reviews with details — clinics with text-rich patient reviews are more trustworthy than star-only ratings
GLP-1 Medications Explained
GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:
- Ozempic & Wegovy — both contain semaglutide. Ozempic is FDA-approved for type 2 diabetes; Wegovy for chronic weight management.
- Mounjaro & Zepbound — both contain tirzepatide (a dual GIP/GLP-1 agonist). Mounjaro for diabetes; Zepbound for weight loss.
- Compounded GLP-1s — Following the April 2026 FDA 503B ruling, compounded GLP-1 medications are no longer available from most pharmacies. Stick with FDA-approved brand-name medications from verified clinics.
Cost & Insurance in Kansas
Kansas Medicaid covers GLP-1 for diabetes only.
For state regulation info, see the Kansas Medical Board.
Frequently Asked Questions
How many GLP-1 clinics are in Topeka?
Our directory lists 19 verified GLP-1 clinics in the Topeka area, with rankings based on patient reviews, services offered, and verified provider status.
Does insurance cover GLP-1 medications in Kansas?
Kansas Medicaid covers GLP-1 for diabetes only.
Are compounded GLP-1 medications still available?
Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.